---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285437997.md"
description: "ADMA Biologics shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY26 sales guidance below estimates."
datetime: "2026-05-06T20:51:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285437997.md)
  - [en](https://longbridge.com/en/news/285437997.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285437997.md)
---

# 

ADMA Biologics shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY26 sales guidance below estimates.

### Related Stocks

- [ADMA.US](https://longbridge.com/en/quote/ADMA.US.md)

## Related News & Research

- [17:28 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA](https://longbridge.com/en/news/286821593.md)
- [20:15 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA](https://longbridge.com/en/news/286483885.md)
- [A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations](https://longbridge.com/en/news/286183122.md)
- [17:24 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA](https://longbridge.com/en/news/286160374.md)
- [Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | IMUX Stock News](https://longbridge.com/en/news/286894992.md)